Faecal Microbiota Transplant (FMT) is effective in treating clostridium difficile (C. difficile) infections that can cause diarrhoea, cramping and other gastrointestinal difficulties, say Canadian scientists.
A combination of four probiotic strains may shorten the duration of an infection with Clostridium difficile, says a new study that supports the role of probiotics to counter the most common cause of hospital-acquired infections.
Probiotic supplements containing Saccharomyces boulardii may reduce the risk of antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea, says a new meta-analysis of 21 randomized controlled trials.
Clostridium difficile infections have been noted by EU and US health authorities as an ‘emerging’ healthcare threat – costing the US $1bn annually. Now, researchers preparing a pilot study are looking at whether probiotics could be a solution.
The International Probiotics Association has identified several issues with the design of a recently published study finding no effect of probiotics on antibiotic associated diarrhea (AAD) or Clostridium difficile diarrhea (CDD). These issues could call...
"We hope these results will prompt physicians to consider its use.”
The capacity of probiotics to ease diarrhoea and other problems associated with antibiotic use in some patients has received fresh backing after a review of studies conducted by University of Toronto researchers.